DK1399472T3 - Oplöselig heterodimer cytokinreceptor - Google Patents

Oplöselig heterodimer cytokinreceptor

Info

Publication number
DK1399472T3
DK1399472T3 DK02713823T DK02713823T DK1399472T3 DK 1399472 T3 DK1399472 T3 DK 1399472T3 DK 02713823 T DK02713823 T DK 02713823T DK 02713823 T DK02713823 T DK 02713823T DK 1399472 T3 DK1399472 T3 DK 1399472T3
Authority
DK
Denmark
Prior art keywords
cytokine receptor
heterodimeric cytokine
soluble heterodimeric
immunoglobulin
subunit
Prior art date
Application number
DK02713823T
Other languages
English (en)
Inventor
Yasmin A Chandrasekher
Donald C Foster
Wenfeng Xu
Stephen R Jaspers
Julia E Novak
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1399472T3 publication Critical patent/DK1399472T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
DK02713823T 2001-03-09 2002-03-07 Oplöselig heterodimer cytokinreceptor DK1399472T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27456001P 2001-03-09 2001-03-09
US29986501P 2001-06-21 2001-06-21
PCT/US2002/007214 WO2002072607A2 (en) 2001-03-09 2002-03-07 Soluble heterodimeric cytokine receptor

Publications (1)

Publication Number Publication Date
DK1399472T3 true DK1399472T3 (da) 2009-10-05

Family

ID=26956904

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02713823T DK1399472T3 (da) 2001-03-09 2002-03-07 Oplöselig heterodimer cytokinreceptor

Country Status (11)

Country Link
EP (1) EP1399472B1 (da)
JP (1) JP4009535B2 (da)
AT (1) ATE432942T1 (da)
AU (1) AU2002245652A1 (da)
CA (1) CA2440596C (da)
DE (1) DE60232511D1 (da)
DK (1) DK1399472T3 (da)
EA (1) EA005496B1 (da)
ES (1) ES2327821T3 (da)
IL (2) IL157726A0 (da)
WO (1) WO2002072607A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2253301A (en) 1999-12-03 2001-06-12 Zymogenetics Inc. Human cytokine receptor
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US20030170823A1 (en) 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US20030023033A1 (en) * 2001-07-26 2003-01-30 Laure Dumoutier Novel class II cytokine receptors and uses thereof
DE60123998T2 (de) 2000-08-08 2007-09-06 Zymogenetics, Inc., Seattle Lösliche zcyctor 11 cytokinrezeptoren
ATE333888T1 (de) 2000-09-15 2006-08-15 Zymogenetics Inc Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
CA2439961A1 (en) 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
AU2012216499B2 (en) * 2001-10-19 2015-05-28 Genentech, Inc. Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
AU2002337920A1 (en) 2001-10-19 2003-04-28 Zymogenetics, Inc. Dimerized growth factor and materials and methods for producing it
CA2467723C (en) 2001-12-17 2011-09-27 Zymogenetics, Inc. Method for treating cervical cancer
CA2475177A1 (en) 2002-02-11 2003-08-21 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
AU2003223344B9 (en) 2002-03-22 2009-07-16 Zymogenetics, Inc. Anti-IL-TIF antibodies and methods of using in inflammation
JP2007525438A (ja) * 2003-03-24 2007-09-06 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法
WO2005014028A1 (en) * 2003-08-08 2005-02-17 Novo Nordisk A/S Interleukin-20 for treating and diagnosing conditions associated with neovascularisation
WO2005052001A2 (en) 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
AU2005299809B2 (en) 2004-10-22 2010-12-02 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
EP1856156A2 (en) 2005-02-08 2007-11-21 ZymoGenetics, Inc. Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
EP1891107B1 (en) 2005-05-12 2011-07-06 ZymoGenetics, Inc. Compositions and methods for modulating immune responses
EP3409289B1 (en) 2010-02-26 2020-09-30 Novo Nordisk A/S Stable antibody containing compositions
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
PE20170441A1 (es) 2014-06-06 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos
MX2017015260A (es) 2015-06-03 2018-02-19 Squibb Bristol Myers Co Anticuerpos anti receptor de factor de necrosis tumoral inducible por glucocorticoide (gitr) para diagnostico del cancer.
GB201514875D0 (en) * 2015-08-20 2015-10-07 Autolus Ltd Receptor
AU2016356780A1 (en) 2015-11-19 2018-06-28 Bristol-Myers Squibb Company Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
CN110869392A (zh) 2017-05-16 2020-03-06 百时美施贵宝公司 用抗gitr激动性抗体治疗癌症

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
EP1141008A1 (en) * 1998-12-31 2001-10-10 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them

Also Published As

Publication number Publication date
EP1399472A4 (en) 2004-06-30
WO2002072607A3 (en) 2004-01-15
ATE432942T1 (de) 2009-06-15
DE60232511D1 (de) 2009-07-16
EP1399472B1 (en) 2009-06-03
AU2002245652A1 (en) 2002-09-24
EA200300983A1 (ru) 2004-06-24
WO2002072607A2 (en) 2002-09-19
IL204299A (en) 2011-06-30
IL157726A0 (en) 2004-03-28
CA2440596A1 (en) 2002-09-19
JP4009535B2 (ja) 2007-11-14
CA2440596C (en) 2011-05-24
EA005496B1 (ru) 2005-02-24
EP1399472A2 (en) 2004-03-24
ES2327821T3 (es) 2009-11-04
JP2004536040A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
DK1399472T3 (da) Oplöselig heterodimer cytokinreceptor
DE60040240D1 (de) Löslicher interleukin-20 rezeptor
DK1576112T3 (da) Cytokin-receptor zcytor17-multimerer
DK1534736T3 (da) Nogo-receptorantagonister
EP1572967A4 (en) IL-1 RECEPTOR-BASED ANTAGONISTS AND MANUFACTURING AND USE METHOD
TW200732350A (en) Methods for generating monovalent IgG
DE69535459D1 (de) Monoklonale antikörper spezifisch gegen vegf-rezeptoren und ihre verwendung
PT663953E (pt) Fagemideos que co-expressam um receptor de superficie e uma proteina heterologa de superficie
DE602004022390D1 (de) Verbesserte fc-fusionsproteine
DK0640689T3 (da) p4-homodimer af interleukin-12.
WO2003004529A3 (en) Ephrin-tie receptor materials and methods
DE69926536D1 (de) Antagonisten von vaskular-endothelialen zellwachstumsfaktoren und ihre anwendung
DK1047781T3 (da) IL-18-receptorer
DE69837606D1 (de) Cystein-reiche rezeptoren-train
DK1642973T3 (da) Terapeutisk anvendelser af BR43X2-oplöselige receptorer
DK0760857T3 (da) Receptor for onkostatin M
ATE490969T1 (de) Modifizierte transferrin-fusionsproteine
DE69333027D1 (de) Fusionsprotein , das zwei rezeptoren des tumornekrose-faktors enthält
EP1660517A4 (en) ANTAGONISTS OF NOGO RECEPTOR
IL139419A (en) Antibodies which cross-react with apo-2l receptor and compositions comprising them
DK1447414T3 (da) Antagonistpeptider af carcinoembronisk antigen (CEA)
EA200600376A1 (ru) Антагонисты nogo-рецептора
EA200400384A1 (ru) Растворимый рецептор т-клетки
HK1080488A (en) Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13rα1)